Switch theme
Sign up to access all valuation multiples
IMCD NV manufactures and sells a variety of chemicals and food ingredients. The firm's product portfolio consists of two categories: Life Science consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care and I&I, and The Industrial segment contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments; EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment.
1995
5.1K+
LTM Revenue $5.4B
LTM EBITDA $663M
$9.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
IMCD has a last 12-month revenue (LTM) of $5.4B and a last 12-month EBITDA of $663M.
In the most recent fiscal year, IMCD achieved revenue of $5.3B and an EBITDA of $662M.
IMCD expects next 12-month revenue of XXX and NTM EBITDA of XXX
See IMCD valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $5.4B | XXX | $5.3B | XXX | XXX | XXX |
| Gross Profit | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| Gross Margin | 25% | XXX | 25% | XXX | XXX | XXX |
| EBITDA | $663M | XXX | $662M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBIT | $526M | XXX | $478M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $385M | XXX | $313M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, IMCD's stock price is EUR 120 (or $134).
IMCD has current market cap of EUR 7.1B (or $7.9B), and EV of EUR 8.2B (or $9.2B).
See IMCD trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $9.2B | $7.9B | XXX | XXX | XXX | XXX | $6.99 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, IMCD has market cap of $7.9B and EV of $9.2B.
IMCD's trades at 1.7x EV/Revenue multiple, and 14.0x EV/EBITDA.
Equity research analysts estimate IMCD's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
IMCD has a P/E ratio of 20.6x.
See valuation multiples for IMCD and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7.9B | XXX | $7.9B | XXX | XXX | XXX |
| EV (current) | $9.2B | XXX | $9.2B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 13.9x | XXX | 14.0x | XXX | XXX | XXX |
| EV/EBIT | 17.6x | XXX | 19.4x | XXX | XXX | XXX |
| EV/Gross Profit | 6.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 20.6x | XXX | 25.4x | XXX | XXX | XXX |
| EV/FCF | 23.9x | XXX | 32.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialIMCD's last 12 month revenue growth is 5%
IMCD's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.2M for the same period.
IMCD's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
IMCD's rule of X is 26% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for IMCD and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | 18% | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 26% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.0M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
IMCD acquired XXX companies to date.
Last acquisition by IMCD was XXXXXXXX, XXXXX XXXXX XXXXXX . IMCD acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was IMCD founded? | IMCD was founded in 1995. |
| Where is IMCD headquartered? | IMCD is headquartered in Netherlands. |
| How many employees does IMCD have? | As of today, IMCD has 5.1K+ employees. |
| Is IMCD publicy listed? | Yes, IMCD is a public company listed on AMS. |
| What is the stock symbol of IMCD? | IMCD trades under IMCD ticker. |
| When did IMCD go public? | IMCD went public in 2014. |
| Who are competitors of IMCD? | Similar companies to IMCD include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of IMCD? | IMCD's current market cap is $7.9B |
| What is the current revenue of IMCD? | IMCD's last 12 months revenue is $5.4B. |
| What is the current revenue growth of IMCD? | IMCD revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of IMCD? | Current revenue multiple of IMCD is 1.7x. |
| Is IMCD profitable? | Yes, IMCD is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of IMCD? | IMCD's last 12 months EBITDA is $663M. |
| What is IMCD's EBITDA margin? | IMCD's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of IMCD? | Current EBITDA multiple of IMCD is 13.9x. |
| What is the current FCF of IMCD? | IMCD's last 12 months FCF is $387M. |
| What is IMCD's FCF margin? | IMCD's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of IMCD? | Current FCF multiple of IMCD is 23.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
